Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy

被引:26
|
作者
Mahon, NG
Coonar, AS
Jeffery, S
Coccolo, F
Akiyu, J
Zal, B
Houlston, R
Levin, GE
Baboonian, C
McKenna, WJ
机构
[1] St George Hosp, Sch Med, Dept Cardiol, London SW17 0RE, England
[2] St George Hosp, Sch Med, Dept Med Genet, London SW17 0RE, England
[3] St George Hosp, Sch Med, Dept Clin Biochem, London SW17 0RE, England
[4] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England
关键词
dilated cardiomyopathy; genetics; haemochromatosis;
D O I
10.1136/heart.84.5.541
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Two common mutations of the haemochromatosis associated gene (HFE) (cys282tyr (C282Y) and his63asp (H63D)) have been implicated in haemochromatosis and as modulators in cardiovascular disease. Objective-To investigate the role of these mutations in the pathogenesis of idiopathic dilated cardiomyopathy. Design and setting-Case-control and prospective cohort study of patients attending a cardiomyopathy unit in a tertiary referral cardiac centre. Methods-207 unrelated white patients with dilated cardiomyopathy, followed up for 259 patient years, and 200 controls were tested for HFE C282Y and H63D mutations by polymerase chain reaction and restriction digestion. Results-31/207 patients (15%) v 24/200 controls (12%) carried C282Y (adjusted odds ratio (OR) 1.2 (95% confidence interval 0.7 to 2.2)), 74/207 (36%) v 53/200 (27%) carried H63D (OR 1.6 (1.1 to 2.5)), and 10/207 (4.8%) v 4/200 (2%) were compound heterozygotes (OR 2.6 (0.8 to 8.5)). Four patients and six controls were H63D homozygous and one was C282Y homozygous. There was a progressive increase in mean serum iron ([Fe]) and transferrin saturations from patients with no mutation ([Fe] = 16.3 mu mol/l, transferrin saturation = 23.7%) through H63D heterozygotes (17.5 mu mol/l, 25.8%), C282Y heterozygotes (17.1 mu mol/l, 26.6%), H63D homozygotes (20.0 mu mol/l, 33.5%), compound heterozygotes (26.8 mu mol/l, 41.7%), and C282Y homozygotes (34 mu mol/l, 71%). At follow up (median 90 months) the rate of death or cardiac transplantation was 52/207 (25%). C282Y heterozygotes had less ventricular dilatation (mean (SD): 59.9 (1.7) mm v 64.9 (0.9) mm, p < 0.05), better fractional shortening (24 (1.7)% v 18.8 (1.4)%, p < 0.01), and a trend towards improved survival without transplantation. [Fe] and transferrin saturation did not correlate with disease severity and were not associated with reduced survival. Conclusions-The frequency of the H63D mutation is significantly increased in patients with idiopathic dilated cardiomyopathy. As H63D has a relatively minor effect on iron status, the mechanism of this association may be unrelated to iron metabolism.
引用
收藏
页码:541 / 547
页数:7
相关论文
共 50 条
  • [31] The role of Lamin A/C mutations in Danish patients with idiopathic dilated cardiomyopathy
    Moller, Daniel Vega
    Pham, Tam Thanh
    Gustafsson, Finn
    Hedley, Paula
    Ersboll, Mads Kristian
    Bundgaard, Henning
    Andersen, Claus B.
    Torp-Pedersen, Christian
    Kober, Lars
    Christiansen, Michael
    EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (11) : 1031 - 1035
  • [32] Mutations in desmosomal genes in heart transplant patients with idiopathic dilated cardiomyopathy
    Garcia-Pavia, P.
    Syrris, P.
    Segovia, J.
    Salas, C.
    Gonzalez-Mirelis, J.
    Gomez-Bueno, M.
    Bornstein, B.
    McKenna, W. J.
    Alonso-Pulpon, L.
    Elliott, P. M.
    EUROPEAN HEART JOURNAL, 2010, 31 : 161 - 161
  • [33] Novel lamin A/C mutations in idiopathic dilated cardiomyopathy and/or conduction disease
    van Tintelen, P
    Katerberg, H
    Boven, L
    Wiesfeld, A
    Wilde, AA
    van Langen, IM
    Rossenbacker, T
    van den Berg, MP
    van Veldhuisen, DJ
    Buys, CH
    Hofstra, R
    Vos, Y
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 152A - 152A
  • [34] Familial dilated cardiomyopathy in patients transplanted for idiopathic dilated cardiomyopathy
    Monserrat, L
    Hermida, M
    Bouzas, B
    Mosquera, I
    Mahon, N
    Peteiro, J
    Alvarez, N
    Penas-Lado, M
    Crespo, M
    Castro-Beiras, A
    REVISTA ESPANOLA DE CARDIOLOGIA, 2002, 55 (07): : 725 - 732
  • [35] Frequency of development of idiopathic dilated cardiomyopathy among relatives of patients with idiopathic dilated cardiomyopathy
    Michels, VV
    Olson, TM
    Miller, FA
    Ballman, KV
    Rosales, AG
    Driscoll, DJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (11): : 1389 - 1392
  • [36] Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy
    Muntoni, F
    Di Lenarda, A
    Porcu, M
    Sinagra, G
    Mateddu, A
    Marrosu, G
    Ferlini, A
    Cau, M
    Milasin, J
    Melis, MA
    Marrosu, MG
    Cianchetti, C
    Sanna, A
    Falaschi, A
    Camerini, F
    Giacca, M
    Mestroni, L
    HEART, 1997, 78 (06) : 608 - 612
  • [37] Variants of resistin gene and the risk of idiopathic dilated cardiomyopathy in Pakistan
    Hussain, Sabir
    Haroon, Javeria
    Ejaz, Shagufta
    Javed, Qamar
    META GENE, 2016, 9 : 37 - 41
  • [38] Novel mutations in phospholamban gene cause hypertrophic cardiomyopathy and dilated cardiomyopathy in Japan
    Fujino, N
    Shimizu, M
    Ino, H
    Yamaguchi, M
    Konno, T
    Mizuno, S
    Fujino, S
    Ueda, K
    CIRCULATION, 2004, 110 (17) : 553 - 553
  • [39] Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy
    van Spaendonck-Zwarts, Karin Y.
    Posafalvi, Anna
    van den Berg, Maarten P.
    Hilfiker-Kleiner, Denise
    Bollen, Ilse A. E.
    Sliwa, Karen
    Alders, Marielle
    Almomani, Rowida
    van Langen, Irene M.
    van der Meer, Peter
    Sinke, Richard J.
    van der Velden, Jolanda
    Van Veldhuisen, Dirk J.
    van Tintelen, J. Peter
    Jongbloed, Jan D. H.
    EUROPEAN HEART JOURNAL, 2014, 35 (32) : 2165 - 2173
  • [40] IDIOPATHIC DILATED CARDIOMYOPATHY - REPLY
    COUGHLIN, SS
    METAYER, C
    EPIDEMIOLOGY, 1994, 5 (03) : 384 - 385